Covington & Burling LLP
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Primarily counselling investors and emerging companies on all aspects of IPOs, M&A, and spinouts, Covington & Burling LLP deploys a ‘straightforward’ approach when handling cross-border transactions. The industries of specialism are mainly pharma, tech, and clean energy, with the team demonstrating vast seed financing knowledge. Gregor Frizzell heads the practice, while James Gubbins mainly focuses on growth-stage investments. James Halstead specialises in complex transactions and acquisitions, Ben Land-Maycock ’embodies that approachable, high-energy personality’, focusing on acting for corporate funds, and both Katy Knight and Trudy Dargeviciute are both highlighted as key ports of call.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The uniqueness of the team stems from the partner James Halstead. He is truly first-in-class, and his leadership shows with the performance of the rest of the team.’
‘James Halstead has an exceptional legal mind, is always there in an emergency and has an amazing knowledge of the UK ventures market. I could not praise him highly enough.#
Key clients
- Abingworth & Novo Holdings
- AstraZeneca
Work highlights
Advised long standing client Abingworth and new client Novo Holding on the £90m Series A Financing for Myricx Bio.